L03 - Immunisation & Immunotherapy Flashcards

1
Q

Define Active Immunisation (Vaccination)

A

Administration of antigen in order to induce active production of immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the characteristics of Active Immunisation

A
Immunity is specific for antigen given
Immunological memory is induced
Immunity involves antibody/T-cell response
Systemic/Mucosal immunity is possible
Protection is not immediate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define Passive Immunisation

A

Administration of pre-formed antibody in order to protect from disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the characteristics of Passive Immunisation

A

No immunological memory is generated
No immune response in the recipient
Protection is immediate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define the Primary Antibody Response

A

Shortly after vaccination
Induces formation of memory cells
Mainly IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define the Secondary Antibody Response

A

After secondary exposure to antigen
Faster, peaks higher
Mainly IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define Live Attenuated Vaccines

A

Vaccines consisting of organisms whose virulence has been reduced ie. by repeated culture in vitro (MMR)
Not possible for all viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the characteristics of LAVs

A

Multiply in the host, mimic natural infection but with no/mild symptoms
Systemic/mucosal immunity forms with long lasting immune memory
Usually only one dose is needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the risks of LAVs

A

Potential for severe infection (immunodeficiency)
Potential to revert to virulent strain
Storage conditions critical for stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define Killed Viruses - Give an example

A

Vaccines consisting of whole inactivated virus/bacteria (Polio)
Not suitable for all organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the characteristics of KVs

A

Do not multiply in the host
Only systemic immunity induced
Several doses needed (large amount of antigen req.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the risks of KVs

A

Inactivation may alter structure
No risk of infection/reversion
More stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define Subunit Vaccines - Give an example

A

Vaccines consisting of parts/products of organisms (Group C Meningococcus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the characteristics of SVs

A

Immunisation does not mimic natural infection BUT induces a response to prevent disease
Only systemic immunity induced
Several doses needed (inc. adjuvant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the risks of SVs

A

No risk of infection/reversion

No unwanted components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give three examples of contraindications to immunisation common to all vaccines

A

Acute illness
Severe reaction to previous dose of same vaccine
Patient known to be allergic to vaccine/component

17
Q

Give three examples of contraindications to immunisation specific to LVs

A

Pregnancy

Primary or Secondary Immunodeficiency

18
Q

Give three examples of situations where vaccines may not work

A

LV given to patients on antibiotics
Patients on immunoglobulin therapy
LVs given close together (give at the same time or weeks apart)

19
Q

Define Immunoglobulin Replacement Therapy

A

A type of passive immunisation where immunoglobulin is given (i.v. or s.c.)

20
Q

How are IVIG preparations produced?

A
Derived from pooled plasma of >1000 donors
IgG must be >90% intact with a range of subclasses
Biologically active (activates complement, binds FcR)
Free of inflammatory mediators/infectious agents
21
Q

What are the indications for the use of IVIG?

A

Primary antibody deficiencies

Secondary antibody deficiencies

22
Q

Describe Hyperimmune/Specific Immunoglobulin Preparations

A

Selected for v. high titres of antibodies to spec. microbes

Used for post-exposure treatment/prophyalxis

23
Q

Define monoclonal antibodies

A

Artificially produced antibodies of a single specificity derived from a single B cell clone

24
Q

Describe the characteristics of MABs

A

Endless supply
Fully homogenous & characterised reagent (highly specific/potent)
Reduced risk of transferring infection

25
Define cytokines
Molecules which activate and regulate the immune response
26
Describe the roles of cytokines
Stimulation of cells of the immune system Stimulation of inflammation Stimulation of haematopoiesis Anti-viral/anti-proliferative activities
27
Define INF-a
INF-a is a cytokine that is used for: Inhibition of viral replication/protein synthesis in infected cells Stimulation of the anti-viral immune response
28
Give two examples of cytokines that enhance circulating neutrophil levels
Granulocyte Colony Stimulating Factor | Granulocyte-Macrophage Colony Stimulating Factor
29
Why are GCSF/GMCSF used?
To reduce duration of neutropenia/incidence of febrile neutropenia (chemo/myeloablative therapy)
30
Define INF-Y
INF-Y is a cytokine used to treat Chronic Granulomatous Disease
31
How is INF-Y used to treat CGD?
INF-Y upregulates activity of NADPH-oxidase (CGD is a primary immunodeficiency due to defective components of phagocyte NADPH-oxidase)